Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc expected to post a loss of 31 cents a share - Earnings Preview

* Mesa Laboratories Inc  MLAB.OQ   MLAB.O  is expected
to show a
rise in quarterly revenue when it reports  results on November 2
(estimated). 
    * The Lakewood Colorado-based  company is expected to report
 a
48.7% increase in revenue to $53.3 million from $35.84 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Mesa Laboratories
Inc is
for a loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $180​, above​ its last closing price of $135.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.91        1.00       -0.27     Missed  -127.1
 Mar. 31 2022  0.48        0.48       -0.34     Missed  -170.8
 Dec. 31 2021  0.42        0.42       0.61      Beat    45.2​
 Sep. 30 2021  0.50        0.42       0.70      Beat    66.7
 ​​Jun.        0.11        0.10       0.38      Beat    280
 30 2021                                                
 Mar. 31 2021  0.18        0.26       0.74      Beat    190.2​
 Dec. 31 2020  0.32        0.33       -0.89     Missed  -373.8
 Sep. 30 2020  0.04        0.06       0.51      Beat    705.3
 This summary was machine generated October 31 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Mesa Laboratories

See all news